Literature DB >> 16877967

Abnormalities of renal sodium handling in the metabolic syndrome. Results of the Olivetti Heart Study.

Pasquale Strazzullo1, Antonio Barbato, Ferruccio Galletti, Gianvincenzo Barba, Alfonso Siani, Roberto Iacone, Lanfranco D'Elia, Ornella Russo, Marco Versiero, Eduardo Farinaro, Francesco P Cappuccio.   

Abstract

OBJECTIVE: The mechanisms underlying high blood pressure in the framework of metabolic syndrome (MS) are not clarified: we thus analyzed the relationship of MS and its components to renal tubular sodium handling among participants of the Olivetti Heart Study, an epidemiological investigation of a representative sample of adult white male population in southern Italy.
METHODS: Proximal (FPRNa) and distal (FDRNa) fractional sodium reabsorption were estimated by the clearance of exogenous lithium in 702 participants aged 25-75 years examined in 1994-1995. Blood pressure and relevant anthropometric and biochemical variables were also measured. The diagnosis of MS was based on modified National Cholesterol Education Program (NCEP)-Adult Treatment Panel III (ATP III) criteria.
RESULTS: FPRNa, but not FDRNa, was directly associated with body mass index (BMI), waist circumference, diastolic pressure, serum triglyceride and uric acid, independently of age and of antihypertensive treatment. After adjustment for age, FPRNa, but not FDRNa, was significantly greater in individuals with MS, as compared to those without [77.6% (95% confidence interval = 76.7-80.1) versus 74.4% (73.7-75.1), P < 0.001]. A similar difference was observed after the exclusion of participants on current antihypertensive treatment (P = 0.018). In untreated individuals, a significant interaction was observed between obesity and insulin resistance as related to FPRNa (P = 0.002): the highest age-adjusted levels of FPRNa were detected in obese hypertensive and obese insulin-resistant participants.
CONCLUSION: In this sample of an adult male population, MS was associated with an increased rate of FPRNa. This finding is relevant to the pathophysiology of MS and possibly to the prevention of its cardiovascular and renal consequences.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16877967     DOI: 10.1097/01.hjh.0000239300.48130.07

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  30 in total

1.  Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients.

Authors:  Elaine M Worcester; Fredric L Coe; Andrew P Evan; Kristin J Bergsland; Joan H Parks; Lynn R Willis; Daniel L Clark; Daniel L Gillen
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-20

Review 2.  The Role of Sympatho-Inhibition in Combination Treatment of Obesity-Related Hypertension.

Authors:  Revathy Carnagarin; Cynthia Gregory; Omar Azzam; Graham S Hillis; Carl Schultz; Gerald F Watts; Damon Bell; Vance Matthews; Markus P Schlaich
Journal:  Curr Hypertens Rep       Date:  2017-10-28       Impact factor: 5.369

Review 3.  Excess Body Weight, Insulin Resistance and Isolated Systolic Hypertension: Potential Pathophysiological Links.

Authors:  Lanfranco D'Elia; Pasquale Strazzullo
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-11-02

4.  Chronic glucose infusion causes sustained increases in tubular sodium reabsorption and renal blood flow in dogs.

Authors:  Michael W Brands; Tracy D Bell; Nancy A Rodriquez; Praveen Polavarapu; Dmitriy Panteleyev
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-10       Impact factor: 3.619

Review 5.  The metabolic syndrome: insulin resistance.

Authors:  Nasser Mikhail
Journal:  Curr Hypertens Rep       Date:  2009-04       Impact factor: 5.369

6.  Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study.

Authors:  Jing Chen; Dongfeng Gu; Jianfeng Huang; Dabeeru C Rao; Cashell E Jaquish; James E Hixson; Chung-Shiuan Chen; Jichun Chen; Fanghong Lu; Dongsheng Hu; Treva Rice; Tanika N Kelly; L Lee Hamm; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2009-02-14       Impact factor: 79.321

Review 7.  The role of obesity in the pathogenesis of hypertension.

Authors:  Yolanda E Bogaert; Stuart Linas
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-23

Review 8.  Aldosterone in salt-sensitive hypertension and metabolic syndrome.

Authors:  Toshiro Fujita
Journal:  J Mol Med (Berl)       Date:  2008-04-25       Impact factor: 4.599

Review 9.  Recommending salt intake reduction to the hypertensive patient: more than just lip service.

Authors:  Pasquale Strazzullo; Lanfranco D'Elia; Giulia Cairella; Luca Scalfi; Michele Schiano di Cola
Journal:  High Blood Press Cardiovasc Prev       Date:  2012-06-01

10.  Polymorphisms in the WNK1 gene are associated with blood pressure variation and urinary potassium excretion.

Authors:  Stephen Newhouse; Martin Farrall; Chris Wallace; Mimoza Hoti; Beverley Burke; Philip Howard; Abiodun Onipinla; Kate Lee; Sue Shaw-Hawkins; Richard Dobson; Morris Brown; Nilesh J Samani; Anna F Dominiczak; John M Connell; G Mark Lathrop; Jaspal Kooner; John Chambers; Paul Elliott; Robert Clarke; Rory Collins; Maris Laan; Elin Org; Peeter Juhanson; Gudrun Veldre; Margus Viigimaa; Susana Eyheramendy; Francesco P Cappuccio; Chen Ji; Roberto Iacone; Pasquale Strazzullo; Meena Kumari; Michael Marmot; Eric Brunner; Mark Caulfield; Patricia B Munroe
Journal:  PLoS One       Date:  2009-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.